Clinical Trial Update: ALTERRA Post-Approval Study

View source ↗

Summary

ALTERRA post-approval study by Edwards Lifesciences is currently ACTIVE_NOT_RECRUITING, focusing on pulmonary valve-related conditions and complex congenital he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Congenital Heart Disease
• Pulmonary Regurgitation
• Pulmonary Valve Insufficiency
• Right Ventricular Outflow Tract Obstruction
• Tetralogy of Fallot

Snippet

Sponsor: Edwards Lifesciences | Conditions: Pulmonary Valve Insufficiency, Complex Congenital Heart Defect | Status: ACTIVE_NOT_RECRUITING